Remove Blogging Remove Sales Remove San Diego Remove Technical Review
article thumbnail

Xconomy Special Report: 12 San Diego Tech Startup to Watch in 2017

Xconomy

View the Slideshow A little more than a year ago, amid a resurgence in San Diego’s software sector, Xconomy identified a baker’s dozen of local tech companies to watch in 2016. Tim Rueth, a UC San Diego entrepreneur in residence and member of the EvoNexus selection committee, also screened the list, and offered his perspective.

article thumbnail

Retro: My Favorite Blog Post on Raising VC

Both Sides of the Table

On December 2nd, 2006 I wrote the blog post published later in this post when I was CEO of startup Koral about my experiences in pitching VCs. After my company was acquired by Salesforce.com I was asked to stop blogging and they took over my blog as an asset in the sale of the company. My blog was wiped out.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Echo Labs Wins “Quick Pitch” Contest with Digital Hybrid Microscope

Xconomy

By popular acclaim, San Diego-based Echo Laboratories founder Eugene Cho claimed top honors, and a $15,000 check, for his two-minute presentation last week in the 10th annual “Quick Pitch” competition, hosted by San Diego’s Tech Coast Angels. He told the audience Revolve sales had generated $1.8

article thumbnail

7 Steps Online Companies Can Take to Manage Sales Tax Exposure

Xconomy

States have been fighting to collect sales taxes from online retailers since the dawn of the e-commerce age. But today, online companies that sell services rather than merchandise also need to be concerned about state sales taxes. For example, medical services are generally not subject to sales tax.

Sales 62
article thumbnail

Bio Roundup: FDA Says No, PCSK9 Value Fight, CRISPR Intrigue & More

Xconomy

The CRISPR news this week doesn’t need a metaphor; the drama that MIT Technology Review reported can stand alone. —The FDA last summer approved two new cholesterol fighting drugs known as PCSK9 inhibitors, but so far the market has rejected them, resulting in paltry sales. Be our guest and try it.).

article thumbnail

Bio Roundup: Trump’s Triumph, Election Fallout, CRISPR Arguments & More

Xconomy

—Xconomy rounded up some post-election thoughts from several local tech and life science leaders , which included a mix of outrage, resiliency, hope, rationalizing, grandstanding, and some calls for calm and reason. billion in yearly sales. Bagger is helping run the transition. CRISPR DEVELOPMENTS. 6 at the U.S.

Patents 87
article thumbnail

Biotech Roundup: Moonshots, Pink Slips, Gilead, Brexit & More

Xconomy

To boost the initiative, which aims to speed the pace of cancer research, FDA said it would consolidate its cancer review divisions under the Oncology Center of Excellence. The technology was funded by the Department of Defense and comes from MIT’s Lincoln Lab. PureTech also bucked the Brexit fallout this week.